Clinical trial NCT06657612: Is Ultrasound-Guided Steroid Injection Less Effective in Carpal Tunnel Syndrome Patients with Bifid Median Nerve?
Official title: Is Ultrasound-Guided Steroid Injection Less Effective in Carpal Tunnel Syndrome Patients with Bifid Median Nerve?: a Focus on Short-Term Efficacy
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Carpal Tunnel Syndrome
Lead sponsor: Beylikduzu State Hospital
Sponsor class: OTHER
First posted: 2024-10-24
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: Patients with mild to moderate carpal tunnel syndrome

Brief summary: The aim of this study is to evaluate the short-term efficacy of ultrasound-guided corticosteroid injection in patients with and without bifid median nerve.

Detailed description: Twenty-five patients with bifid median nerve and twenty-five patients without bifid median nerve, aged 18-65, who applied to the Physical Therapy and Rehabilitation outpatient clinic at Beylikdüzü State Hospital, diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies, and who received ultrasound-guided corticosteroid injection, will be included in our study. Patients identified as having a bifid median nerve during the injection will be noted and invited for a follow-up at the 1st month to assess their pain and functional status. The same follow-up visit will be conducted for an equal number of age- and gender-matched patients without bifid median nerve who received the injection. At the end of the study, the 1-month efficacy of the injection in both groups will be evaluated. Patients who agree to participate in the study will be asked to complete the Visual Analog Scale (VAS), the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ), and the Quick Disabilities of the Arm, Shoulder, and Hand Questionnaire (Quick-DASH) before the injection. They will then be invited for a follow-up visit at the 1st month, where the VAS, BCTQ, and Quick-DASH will be administered again.

Eligibility criteria: Inclusion Criteria:

* Patients aged 18-65.
* Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies conducted within the last 6 months.
* Scheduled for ultrasound-guided corticosteroid injection.
* Patients who have agreed to participate in the study.

Exclusion Criteria:

* Diagnosis of any other condition that could cause neuropathic symptoms, such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome.
* Previous history of injection or surgery for carpal tunnel syndrome
* Patients who refuse to participate in the study.

Primary outcomes:
measure: Visual Analog Scale (VAS):
timeFrame: 0 day, 4th week
measure: Boston Carpal Tunnel Syndrome Questionnaire Symptom Severity Scale (BCTQ-SSS):
timeFrame: 0 day, 4th week
measure: Quick Disabilities of the Arm, Shoulder, and Hand Questionnaire (Quick-DASH):
timeFrame: 0 day, 4th week
measure: Boston Carpal Tunnel Syndrome Questionnaire Functional Status Scale (BCTQ-FSS):
timeFrame: 0 day, 4th week
Secondary outcomes:
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Beylikdüzü State Hospital
state: Beylikdüzü
Study officials:
References: